Edition:
United Kingdom

Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

182.00SEK
24 Apr 2019
Change (% chg)

-- (--)
Prev Close
182.00kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,687
52-wk High
216.50kr
52-wk Low
115.00kr

About

Infant Bacterial Therapeutics AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): kr749.96
Shares Outstanding(Mil.): 5.28
Dividend: --
Yield (%): --

Financials

  IBTb.ST Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -8.91 -- --
ROI: -42.09 14.23 13.83
ROE: -42.09 15.46 15.25

BRIEF-Infant Bacterial Therapeutics AB Announces First Distribution Agreement

* SIGNED FIRST DISTRIBUTION AGREEMENT FOR IBP-9414 WITH MEGAPHARM LTD. FOR THE ISRAELI MARKET AND THE PALESTINIAN AUTHORITY'S TERRITORIES

06 Mar 2019

Earnings vs. Estimates